Insys Therapeutics posts 4Q revenue of $66.5 million, result beats expectations

MarketsAssociated Press

Insys Therapeutics Inc. (INSY) on Tuesday reported fourth-quarter net income of $9.3 million.

On a per-share basis, the Chandler, Arizona-based company said it had net income of 25 cents. Earnings, adjusted for stock option expense, were 53 cents per share.

Continue Reading Below

The specialty pharmaceutical company posted revenue of $66.5 million in the period, surpassing Street forecasts. Analysts expected $64.6 million, according to Zacks.

For the year, the company reported profit of $38 million, or $1.04 per share. Revenue was reported as $222.1 million.

Insys Therapeutics shares have risen 33 percent since the beginning of the year. The stock has increased 25 percent in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on INSY at


Keywords: Insys Therapeutics, Earnings Report